Mike Doustdar, CEO of Novo Nordisk, discusses the company's GLP-1 pill following the release of the company's Q1 earnings.
Hvor er det et fint interwiev... Meget andeledes end det med CEO fra EL forleden. -Der er gode insights, gode spørgsmål og behagelig tilstedeværelse.. Jeg synes, Mike D. gør det godt!! - Ikke mindst som sælger i mange sammenhænge - som i denne. Hele narrativet: Tiderne skifter! - bliver sunget ind som et enkelt - men gentaget tema.
6/5 2026 22:17 ProInvestorNEWS 3
132231 CNBC's Angelica Peebles speaks with Novo Nordisk CEO Mike Doustdar about the company's quarterly report, the strong launch of the Wegovy pill and what else Novo Nordisk has to come in the pipeline. He says he's always open to doing deals that will strengthen the portfolio and it's part of the company's mindset not to become to complacent or arrogant about Novo's "fantastic" pipeline as it stands.
